EntrarCadastrar

/

Sorafenib

CAS 284461-73-0

Visão geral

Sorofeni is a kinase inhibitor drug approved for the treatment of primary kidney cancer, advanced primary liver cancer, FLT3-ITD positive AML, and radioactive iodine resistant advanced thyroid carcinoma

A Anant Labs fabrica e fornece impurezas de Sorafenib de alta qualidade para o mercado global. Nossas impurezas EP de Sorafenib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.

Ingrediente Farmacêutico Ativo

Chemical structure of Sorafenib

Sorafenib

CAS: 284461-73-0
Mol. Formula: C₂₁H₁₆ClF₃N₄O₃
Mol. Weight: 464.831

Impurezas (5)

Chemical structure of 4-(4-Aminophenoxy)-N-methyl picolinamide

4-(4-Aminophenoxy)-N-methyl picolinamide

Cat. No.: ANT-SRF-03
CAS: 284462-37-9
Mol. Formula: C₁₃H₁₃N₃O₂
Mol. Weight: 243.27

Chemical structure of Phenyl Chloroformate

Phenyl Chloroformate

Cat. No.: ANT-SRF-005
CAS: 1885-14-9
Mol. Formula: C₇H₅ClO₂
Mol. Weight: 156.57

Chemical structure of Sorafenib EP Impurity C

Sorafenib EP Impurity C

Cat. No.: ANT-SRF-006
CAS: 320-51-4
Mol. Formula: C₇H₅ClF₃N
Mol. Weight: 195.57

Chemical structure of Sorafenib Impurity E

Sorafenib Impurity E

Cat. No.: ANT-SRF-02
CAS: 284670-98-0
Mol. Formula: C₂₇H₂₄N₆O₅
Mol. Weight: 512.53

Chemical structure of Sorafenib Impurity H

Sorafenib Impurity H

Cat. No.: ANT-SRF-01
CAS: 1431697-81-2
Mol. Formula: C₂₁H₁₆ClF₃N₄O₃
Mol. Weight: 464.83